Insulin therapy in insulin resistance: Could it be part of a lethal pathway?
- 1 June 2015
- journal article
- editorial
- Published by Elsevier in Atherosclerosis
- Vol. 240 (2) , 400-401
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- β-Cell Function Preservation After 3.5 Years of Intensive Diabetes TherapyDiabetes Care, 2012
- Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?Diabetes, Obesity and Metabolism, 2011
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsBMJ, 2011
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort studyDiabetes, Obesity and Metabolism, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Cardiovascular events and insulin therapy: A retrospective cohort analysisDiabetes Research and Clinical Practice, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failureAmerican Heart Journal, 2005
- Insulin treatment and cardiovascular disease; friend or foe? A point of viewDiabetic Medicine, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998